• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pharmacokinetics of antibiotics in the lungs.

作者信息

Valcke Y, Pauwels R, Van der Straeten M

机构信息

Dept of Respiratory Diseases, University Hospital, Ghent, Belgium.

出版信息

Eur Respir J. 1990 Jun;3(6):715-22.

PMID:2199210
Abstract

This paper reviews current knowledge on the relationship between local penetration or antibiotics and therapeutic efficacy in pulmonary and bronchial infections. The antimicrobial drug concentration at the site of infection is supposedly determinative for the efficacy of the antibiotic treatment but the number of studies in respiratory infections supporting this hypothesis is limited. The mechanisms responsible for the pulmonary deposition or orally or systemically administered antibiotics include passive diffusion, active transport, bulk flow and permeation. The penetration of antimicrobial drugs into the respiratory tract is influenced by both host-related factors, such as inflammation or mechanical injury, and drug-related factors, such as molecular weight. In addition, local bio-inactivation can occur. The final bioactive antibiotic concentration at the site of the respiratory infection is, therefore, the result or a very complex dynamic process. Different sampling and measuring methods have been used for the assessment of antibiotic concentrations at the site of respiratory infections. Concentrations in sputum, bronchial secretions and biopsy specimens have been correlated with serum concentrations and clinical outcome. Bronchoalveolar lavage could be a promising technique for evaluating antibiotic drug concentrations in alveolar lining fluid. For many antibiotics, data concerning penetration and pharmacokinetic behaviour in the respiratory tract are lacking.

摘要

相似文献

1
Pharmacokinetics of antibiotics in the lungs.
Eur Respir J. 1990 Jun;3(6):715-22.
2
Antimicrobial drug concentrations and sampling techniques in the equine lung.马肺部的抗菌药物浓度和采样技术。
Vet J. 2012 Aug;193(2):326-35. doi: 10.1016/j.tvjl.2012.02.010. Epub 2012 Mar 25.
3
Delivering antibacterials to the lungs: considerations for optimizing outcomes.将抗菌药物输送至肺部:优化治疗效果的考量因素
Am J Respir Med. 2002;1(4):261-72. doi: 10.1007/BF03256617.
4
[Pharmacokinetic basis for antibiotic therapy in broncho-pulmonary bacterial infections (author's transl)].
Rev Fr Mal Respir. 1982;10(3):195-203.
5
Predicting the efficacy of antimicrobial agents in respiratory infections--is tissue concentration a valid measure?预测抗菌药物在呼吸道感染中的疗效——组织浓度是一项有效的衡量指标吗?
J Antimicrob Chemother. 1995 Mar;35(3):363-71. doi: 10.1093/jac/35.3.363.
6
Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections.药代动力学和药效学在呼吸道感染抗菌治疗中的应用。
Clin Lab Med. 2004 Jun;24(2):477-502. doi: 10.1016/j.cll.2004.03.009.
7
Optimal antibiotic dosing. The pharmacokinetic-pharmacodynamic interface.最佳抗生素给药剂量。药代动力学-药效学界面。
Postgrad Med. 2000 Dec;108(7 Suppl Contemporaty):17-24. doi: 10.3810/pgm.12.2000.suppl10.52.
8
[Contribution of experimental models to the treatment of respiratory tract infections].
Pathol Biol (Paris). 1989 Jun;37(6):754-8.
9
Antibiotic pharmacokinetic considerations in pulmonary infections.
Semin Respir Infect. 1991 Sep;6(3):168-82.
10
Tissue penetration of antibacterial agents: how should this be incorporated into pharmacodynamic analyses?抗菌药物的组织穿透性:应如何将其纳入药效学分析?
Curr Opin Pharmacol. 2007 Oct;7(5):498-504. doi: 10.1016/j.coph.2007.05.003. Epub 2007 Jul 5.

引用本文的文献

1
Rifaximin potentiates clarithromycin against and in zebrafish.利福昔明增强克拉霉素对斑马鱼体内及体外的抗菌活性。 (注:原英文句子不太完整,根据语境补充了“抗菌活性”使译文更通顺,若严格按要求应是“利福昔明增强克拉霉素对斑马鱼体内及体外的(作用)” )
JAC Antimicrob Resist. 2023 May 8;5(3):dlad052. doi: 10.1093/jacamr/dlad052. eCollection 2023 Jun.
2
How to Use Nebulized Antibiotics in Severe Respiratory Infections.如何在严重呼吸道感染中使用雾化抗生素
Antibiotics (Basel). 2023 Jan 28;12(2):267. doi: 10.3390/antibiotics12020267.
3
Synchrotron-based X-ray fluorescence microscopy reveals accumulation of polymyxins in single human alveolar epithelial cells.
基于同步加速器的X射线荧光显微镜揭示了多粘菌素在单个肺泡上皮细胞中的积累。
Antimicrob Agents Chemother. 2023 May 1;65(5). doi: 10.1128/AAC.02314-20. Epub 2021 Mar 1.
4
Deaths Associated with Pneumonic Plague, 1946-2017.1946 - 2017年与肺鼠疫相关的死亡病例
Emerg Infect Dis. 2020 Oct;26(10):2432-2434. doi: 10.3201/eid2610.191270.
5
Clinical Utility of Lefamulin: If Not Now, When?乐伐莫林的临床效用:若非此时,更待何时?
Curr Infect Dis Rep. 2020;22(9):25. doi: 10.1007/s11908-020-00732-z. Epub 2020 Jul 9.
6
Moxifloxacin in Chronic Obstructive Pulmonary Disease: Pharmacokinetics and Penetration into Bronchial Secretions in Ward and Intensive Care Unit Patients.莫西沙星在慢性阻塞性肺疾病中的应用:住院患者和重症监护病房患者的药代动力学和支气管分泌物穿透率。
Antimicrob Agents Chemother. 2019 Feb 26;63(3). doi: 10.1128/AAC.01974-18. Print 2019 Mar.
7
First Case of Pleural Empyema Caused by : Review of the Literature.首例由……引起的胸膜脓胸:文献综述
Case Rep Infect Dis. 2018 Oct 11;2018:7831284. doi: 10.1155/2018/7831284. eCollection 2018.
8
Nebulization of antimicrobial agents in mechanically ventilated adults in 2017: an international cross-sectional survey.2017 年机械通气成人抗菌药物雾化治疗:国际横断面调查。
Eur J Clin Microbiol Infect Dis. 2018 Apr;37(4):785-794. doi: 10.1007/s10096-017-3175-5. Epub 2018 Jan 9.
9
Aminoglycosides for Treatment of Bacteremia Due to Carbapenem-Resistant Klebsiella pneumoniae.氨基糖苷类药物用于治疗耐碳青霉烯类肺炎克雷伯菌所致菌血症
Antimicrob Agents Chemother. 2016 Apr 22;60(5):3187-92. doi: 10.1128/AAC.02638-15. Print 2016 May.
10
Moxifloxacin pharmacokinetics and pleural fluid penetration in patients with pleural effusion.莫西沙星在胸腔积液患者中的药代动力学及胸膜腔穿透情况。
Antimicrob Agents Chemother. 2014;58(3):1315-9. doi: 10.1128/AAC.02291-13. Epub 2013 Dec 9.